ABOUT
We are delivering transformational medicines through 3D deep learning and cutting-edge drug discovery technologies.
By applying revolutionary insights in 3D protein-ligand co-folding, we seek to target previously undruggable disease targets.
INVESTORS
TECHNOLOGY
Using revolutionary 3D deep learning co-folding technology combined with state of the art lab facilities, we are developing a pipeline of truly novel small molecule inhibitors targeting cancers and other diseases with high unmet medical need.
CHARM Therapeutics’ proprietary DragonFold technology, inspired by the breakthroughs of our co-founder, the Wiley Prize winner David Baker, provides the first rapid, accurate protein/ligand co-folding algorithm.
85
of the human proteome remains undruggable
50
USD Series A
180
protein structures have been solved through structural biology
3
more powerful AI devices every 2 years (Huang's Law)
300
cancer-causing genes
10
patients die due to cancer every year
CAREERS
We are an energetic, entrepreneurial team. We aim to solve some of the biggest problems in drug discovery with next generation AI.
As we continue to grow, we are looking for curious, collaborative and entrepreneurial exceptional individuals to join our team.
Dynamic
Interdisciplinary
Diverse
